Intravenous Artesunate for Severe Malaria in Travelers, Europe

Intravenous Artesunate for Severe Malaria in Travelers, Europe

Multicenter trials in Southeast Asia have shown better survival rates among patients with severe malaria, particularly those with high parasitemia levels, treated with intravenous (IV) artesunate than among those treated with quinine. In Europe, quinine is still the primary treatment for severe mala...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Thomas Zoller, Thomas Junghanss, Annette Kapaun, Ida Gjørup, Joachim Richter, Mats Hugo-Persson, Kristine Mørch, Behruz Foroutan, Norbert Suttorp, Salih Yürek, Holger Flick
Formaat: Artikel
Taal:English
Gepubliceerd in: Centers for Disease Control and Prevention 2011-05-01
Reeks:Emerging Infectious Diseases
Onderwerpen:
artesunate
Plasmodium falciparum
parasites
malaria
hemolysis
critical care
Online toegang:https://wwwnc.cdc.gov/eid/article/17/5/10-1229_article

Internet

https://wwwnc.cdc.gov/eid/article/17/5/10-1229_article

Gelijkaardige items